-
The Future of AAV Research: New Tools Driving Breakthroughs in Gene Therapy
What’s included: What are AAVs? What is Huntington’s disease? Recent developments for AAVs and Huntington’s disease Nicoya’s AAVX and AAV9 capture kits What are AAVs? Adeno-associated viru...
-
Customer Spotlight: How CROs can access SPR with Alto
Learn how Radix BioSolutions®, a CRO based in Georgetown, Texas, has expanded its service offerings through the use of Nicoya’s Alto™ platform. Like many global CROs, Radix BioSolutions has been ...
-
Streamline development and enhance compliance with the Alto GxP Suite
The world’s most user-friendly SPR system can now support regulated workflows! Achieving FDA approval for a new drug is hard, but getting the binding assay data you need for it doesn’t have to...
-
DART.2: Duke scientists make innovation in precision drug delivery
Researchers at Duke University led by Dr. Michael Tadross made a significant contribution to the field of neuroscience by introducing a cutting-edge method called DART.2 (Drug Acutely Restricted by Te...
-
Researcher Spotlight: Uncovering the molecular mechanisms of muscle function using OpenSPR
Learn about how OpenSPR user Sabrina Apel employs Nicoya’s SPR technology to study protein-protein interactions that regulate muscle function. Sabrina Apel is a PhD candidate at the University o...
-
From bench to publication: How OpenSPR® has galvanized label-free studies of diseases across the globe
Explore how OpenSPR is advancing disease research in over 200 peer-reviewed publications Affordability and ease of use have made OpenSPR® a powerful tool in labs worldwide, providing high-quality bin...
-
Epitope characterization made easy: How Digital SPR redefines the antibody workflow
Galvanize your productivity with Alto’s epitope binning application: Pre-designed, intuitive, and sample-friendly. Early antibody discovery involves the screening of a large number of molecules to i...
-
2022 wrapped: Celebrating 10 years at Nicoya
We took a moment to look back on the key events that shaped this milestone year. By Ryan Denomme, Co-Founder and CEO Quick links A year of milestones What’s new for our users? Learnings from the fie...
-
SPR vs BLI: Comparing label-free tools for Fc receptor characterization
Alto™ streamlines the characterization of Fc gamma receptors in our latest app note comparing analysis with Digital SPR and BLI. Fc receptors (FcR), named for their binding specificity to the fragme...
-
New Nature study reveals insights into de novo autoreactivity in severe COVID-19 using Alto™ Digital SPR
Kinetic analysis of de novo autoreactivity in severe COVID-19 reveals important implications for early intervention and treatment in patients with post-COVID sequelae. The SARS-CoV-2 outbreak was firs...